How to Eliminate Ascites in Patients with Liver Disease
Feb 23, 2022
Source: Cainiu Health
Dr. Zhou Fang
Introduction
Patients with hepatic ascites often experience significant abdominal distension due to large-volume ascites, accompanied by bilateral lower-limb edema, severely impairing their quality of life. To alleviate patient discomfort, active treatment is essential. Management strategies for hepatic ascites vary depending on the volume of fluid accumulation. In cases of minimal ascites, appropriate diuretic therapy is usually sufficient to effectively reduce ascites.
Hepatic ascites is a typical complication of end-stage liver cirrhosis; its onset often signifies progression to the advanced stage of cirrhosis. Life expectancy for patients with hepatic ascites largely depends on their overall physical condition and the effectiveness of treatment measures. Below, we address the question of how to manage and resolve hepatic ascites in affected patients.
How to Manage and Resolve Hepatic Ascites
Patients with hepatic ascites often experience marked abdominal distension and bilateral lower-limb edema due to large-volume ascites, severely impairing quality of life. To alleviate patient discomfort, active treatment is essential.
Management strategies for resolving hepatic ascites vary depending on the volume of ascitic fluid present. For mild (small-volume) ascites, diuretic therapy alone is usually sufficient to effectively reduce fluid accumulation.
For moderate-to-severe (large-volume) ascites, therapeutic paracentesis—removal of ascitic fluid via abdominal puncture—may be considered, based on the patient’s tolerance and residual hepatic function. This procedure helps reduce ascites formation. Concurrently, serum albumin levels should be monitored; if hypoalbuminemia is present, intravenous human albumin supplementation should accompany paracentesis to facilitate ascites resolution.
During ascites management, close monitoring of liver function is required. Hepatoprotective and enzyme-lowering medications should be administered as appropriate. Additionally, vigilance for complications—including hepatic encephalopathy, upper gastrointestinal bleeding, hepatic coma, and spontaneous bacterial peritonitis—must be maintained. Treatment plans should be adjusted according to the patient’s clinical status.
During diuretic-induced diuresis and edema reduction, clinicians must consider potential adverse effects such as hypotension or precipitated hepatic encephalopathy. Therefore, initial paracentesis should not exceed 1,000 mL; subsequent procedures should generally be limited to no more than 3,000 mL to prevent hypotension or hepatic encephalopathy.
In patients receiving long-term diuretic therapy, regular monitoring of serum electrolytes—including potassium, sodium, chloride, and calcium—is essential to prevent complications such as hypokalemia or hyponatremia and to avoid electrolyte imbalances and acid-base disturbances.
The above outlines key approaches to managing and resolving hepatic ascites. We hope this information proves helpful to you.
